Congress of European Crohn's and Colitis Organisation

Healio brings you the highlights from the Congress of European Crohn's and Colitis Organisation. Refer back to this page often for the latest news from ECCO, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Stelara maintains clinical response, remission through 2 years in Crohn's disease

February 17, 2017
Patients with moderate-to-severe active Crohn’s disease maintained clinical response and remission with Stelara for up to 2 years, according to…
Meeting News Coverage

FITZROY: Filgotinib induces clinical remission in moderate-to-severe Crohn’s disease

April 5, 2016
Filgotinib safely and effectively induced clinical remission and response in patients with moderate-to-severe Crohn’s disease, according to…
Meeting News Coverage

FMT induces remission in resistant ulcerative colitis

April 4, 2016
Intense multi-donor fecal microbiota transplantation administered via colonoscopy and enema effectively induced clinical and endoscopic remission in…
Meeting News Coverage

TOUCHSTONE: Patients with UC achieve histological improvements with ozanimod

March 24, 2016
Patients with moderate to severe ulcerative colitis achieved histologic improvement and histologic remission with 1 mg ozanimod, according to results…
Meeting News Coverage

Superior endoscopic improvement achieved when azathioprine added to Humira therapy in Crohn’s disease

March 23, 2016
Comparable clinical efficacy was achieved with Humira monotherapy and combination therapy with Humira and azathioprine in patients with Crohn’s…
Meeting News Coverage

GEMINI: UC patients achieve long-term clinical improvement with Entyvio

March 22, 2016
Patients with moderate to severely active ulcerative colitis reported clinical improvements with up to 3 years of treatment with Entyvio, according…
Meeting News Coverage

Survey: IBD specialists well informed, more confident about using biosimilars

March 22, 2016
Inflammatory bowel disease specialists are generally well informed about biosimilars, and concerns regarding their use in clinical practice have…
Meeting News Coverage

Xeljanz induces remission in patients with ulcerative colitis; modest results in Crohn’s trials

March 21, 2016
Xeljanz rapidly induced remission in patients with moderate-to-severe ulcerative colitis, according to results from the OCTAVE 1 and 2 trials…
Meeting News Coverage

GO-COLITIS: Simponi induces clinical response in patients with ulcerative colitis

March 21, 2016
Simponi induced clinical response in more than two-thirds of patients with moderate-to-severe ulcerative colitis in the induction phase of the…
Meeting News Coverage

UNITI-1: Stelara induction therapy safe, effective in moderate-to-severe refractory Crohn’s disease

March 18, 2016
Stelara was well tolerated and induced clinical response and remission in patients with moderate-to-severe Crohn’s disease refractory to…
Healio Jobs